Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival benefits for patients aged 60 and younger compared to bioprosthetic valves.

“The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement,” said Dr. Michael Bowdish, lead author of the study ...

The researchers reviewed data on nearly 110,000 patients who underwent surgical replacement of aortic valves between the ages ...

In contrast, bioprosthetic valves can be expected ... which is my preference in this age group, is the only aortic valve replacement procedure that results in a late survival curve equivalent ...

"The decision between a bioprosthetic and a mechanical valve is one of the most consequential for patients requiring aortic valve replacement," said Dr. Michael Bowdish, lead author of the study ...

Aortic valve reconstruction, particularly through neocuspidization techniques, has emerged as a promising alternative to traditional aortic valve replacement. The Ozaki procedure, which utilizes ...

Nat Clin Pract Cardiovasc Med. 2008;5(12):764-765. We believe that strategies to avoid or reduce the severity of PPM should be individualized and take into account multiple variables, such as ...

LOS ANGELES, CA—In patients ages 60 years or younger undergoing surgical aortic valve replacement, mechanical valves are associated with a survival benefit compared with bioprosthetic valves, ...

CALC is the principal failure mode of BHV fabricated from glutaraldehyde pretreated porcine aortic valves or bovine pericardium. Covalent binding of APD to residual glutaraldehyde in pericardial ...

“The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement,” study leader Dr. Michael Bowdish of Cedars-Sinai ...